A, M., MV, C., E, M., S, C., F, B., MV, G., . . . F, P. (2025). Recurrence Risk in Pediatric Noninfectious Uveitis During Adalimumab Tapering: An International Multicenter Retrospective Study. Arthritis & rheumatology (Hoboken, N.J.), 77(9), 1254. https://doi.org/10.1002/art.43165
Chicago Style (17th ed.) CitationA, Marino, et al. "Recurrence Risk in Pediatric Noninfectious Uveitis During Adalimumab Tapering: An International Multicenter Retrospective Study." Arthritis & Rheumatology (Hoboken, N.J.) 77, no. 9 (2025): 1254. https://doi.org/10.1002/art.43165.
MLA (9th ed.) CitationA, Marino, et al. "Recurrence Risk in Pediatric Noninfectious Uveitis During Adalimumab Tapering: An International Multicenter Retrospective Study." Arthritis & Rheumatology (Hoboken, N.J.), vol. 77, no. 9, 2025, p. 1254, https://doi.org/10.1002/art.43165.